Treatment of Suspected Drug Rash
The first step in treating a suspected drug rash is immediate discontinuation of the suspected causative medication, followed by appropriate symptomatic treatment based on the severity of the rash. 1
Initial Assessment and Classification
When evaluating a suspected drug rash, consider:
- Timing: When did the rash appear in relation to drug exposure?
- Appearance: Distribution, morphology (macular, papular, vesicular, etc.)
- Associated symptoms: Fever, mucosal involvement, systemic symptoms
- Severity indicators: Extent of skin involvement, presence of blisters, epidermal detachment
Treatment Algorithm Based on Severity
Mild to Moderate Drug Rash (Limited body surface area, no systemic symptoms)
- Discontinue the suspected causative drug 1
- Symptomatic treatment:
- Topical moderate-potency corticosteroids (e.g., hydrocortisone 1%) applied 1-2 times daily for 1-2 weeks 1, 2
- Oral antihistamines for pruritus:
- Non-sedating (daytime): Loratadine 10mg daily
- Sedating (nighttime): Diphenhydramine 25-50mg or hydroxyzine 25-50mg 1
- Emollients and moisturizers to keep skin hydrated 1
- Avoid hot water and skin irritants 1
Moderate to Severe Drug Rash (>30% BSA or with troublesome symptoms)
- Discontinue the suspected causative drug immediately 1
- Systemic treatment:
Severe Drug Rash with Systemic Symptoms (DRESS) or Epidermal Detachment (SJS/TEN)
- Immediate discontinuation of all potential culprit drugs 1
- Urgent referral to specialized care (dermatology, burn unit, or intensive care) 1
- Supportive care:
Special Considerations
For Anaphylactic Reactions
If the rash is part of an anaphylactic reaction, immediate treatment includes:
- Epinephrine (intramuscular)
- Hydrocortisone (IV or IM): 200mg for adults 1
- Chlorphenamine (IV or IM): 10mg for adults 1
For Acneiform Rash (Common with EGFR inhibitors)
- Oral antibiotics for 6 weeks (doxycycline 100 mg b.i.d., minocycline 50 mg b.i.d., or oxytetracycline 500 mg b.i.d.) 1
- Topical low/moderate potency steroids 1
- For grade ≥3: Interrupt causative drug and add systemic corticosteroids 1
Prevention of Rebound Flares After Steroid Discontinuation
For patients requiring systemic steroids, prevent rebound flares by:
- Maintaining the effective dose for 2-3 weeks before tapering 5
- Implementing a slow taper over 3 months for severe cases 5
- Introducing antihistamines or other anti-inflammatory treatments toward the end of the taper 5
Follow-up and Documentation
- Document all details of the reaction and suspected drugs
- Consider referral to an allergy specialist for future drug selection 1
- Provide the patient with information about the culprit drug to avoid future exposure
Common Pitfalls to Avoid
- Continuing the suspected drug: This can worsen the reaction and lead to more severe outcomes 1
- Tapering steroids too quickly: This can cause rebound flares 5
- Overlooking potential cross-reactivity: Be cautious when selecting alternative medications 6
- Missing signs of severe reactions: Watch for mucosal involvement, blistering, or systemic symptoms that may indicate life-threatening conditions like SJS/TEN or DRESS 7
By following this approach, most drug rashes can be effectively managed while minimizing the risk of progression to more severe reactions.